BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer

NCT01263782 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Carboplatin
DRUG: Pemetrexed
DRUG: Bevacizumab
DRUG: Cixutumumab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]